Schedule 13D ownership disclosure

Oncobiologics, Inc.

Security class unavailable · CUSIP: 68235M105

Event date: 2018-11-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
99,296,382
Percent of class
78.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-058764
Form type
SC 13D/A
Filer
BioLexis Pte Ltd.
CIK
CIK 1716335
Filed
Nov 09, 2018
Reporting period
Nov 07, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub